Abstract
Composite scaffold comprised of hollow hydroxyapatite (HA) and chitosan (designated hHA/CS) was prepared as a delivery vehicle for recombinating human bone morphogenetic protein-2 (rhBMP-2). The in vitro and in vivo biological activities of rhBMP2 released from the composite scaffold were then investigated. The rhBMP-2 was firstly loaded into the hollow HA microspheres, and then the rhBMP2-loaded HA microspheres were further incorporated into the chitosan matrix. The chitosan not only served to bind the HA microspheres together and kept them at the implant site, but also effectively modified the release behavior of rhBMP-2. The in vitro release and bioactivity analysis confirmed that the rhBMP2 could be loaded and released from the composite scaffolds in bioactive form. In addition, the composite scaffolds significantly reduced the initial burst release of rhBMP2, and thus providing prolonged period of time (as long as 60 days) compared with CS scaffolds. In vivo bone regenerative potential of the rhBMP2-loaded composite scaffolds was evaluated in a rabbit radius defect model. The results revealed that the rate of new bone formation in the rhBMP2-loaded hHA/CS group was higher than that in both negative control and rhBMP2-loaded CS group. These observations suggest that the hHA/CS composite scaffold would be effective and feasible as a delivery vehicle for growth factors in bone regeneration and repair.
Similar content being viewed by others
References
Lee JW, Kang KS, Lee SH, Kim JY, Lee BK, Cho DW. Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres. Biomaterials. 2011;32:744–52.
Ji Y, Xu GP, Zhang ZP, Xia JJ, Yan JL, Pan SH. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng. 2010;38:632–9.
Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials. 2008;29:4195–204.
Berner A, Boerckel JD, Saifzadeh S, Steck R, Ren J, Vaquette C, et al. Biomimetic tubular nanofiber mesh and platelet rich plasma-mediated delivery of BMP-7 for large bone defect regeneration. Cell Tissue Res. 2012;347:603–12.
Berner A, Reichert JC, Muller MB, Zellner J, Pfeifer C, Dienstknecht T, et al. Treatment of long bone defects and non-unions: from research to clinical practice. Cell Tissue Res. 2012;347:501–19.
Leeuwenburgh SCG, Jo J, Wang HN, Yamamoto M, Jansen JA, Tabata Y. Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration. Biomacromolecules. 2010;11:2653–9.
Liu Y, Wu G, de Groot K. Biomimetic coatings for bone tissue engineering of critical-sized defects. J R Soc Interface. 2010;7(Suppl 5):S631–47.
Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, et al. Silk implants for the healing of critical size bone defects. Bone. 2005;37:688–98.
Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP. Bioactive glass in tissue engineering. Acta Biomater. 2011;7:2355–73.
Mouriño V, Boccaccini AR. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface. doi:10.1098/rsif.2009.0379
Wei G, Jin Q, Giannobile WV, Ma PX. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials. 2007;28:2087–96.
Wu B, Zheng Q, Guo X, Wu Y, Wang Y, Cui F. The enhancement of osteogenesis by scaffold based on mineralized recombinant human-like collagen loading with rhBMP-2. J Wuhan Univ Tech Mater Sci Ed. 2009;24:956–60.
Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev. 2003;55:1613–29.
Wang CK, Ho ML, Wang GJ, Chang JK, Chen CH, Fu YC, Fu HH. Controlled-release of critical rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials. 2009;30:4178–86.
Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine. 2006;31:542–7.
Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem. 2007;46:7548–58.
Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, Classic KL, et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials. 2008;29:3245–52.
Niu X, Fan Y, Liu X, Li X, Li P, Wang J, et al. Repair of bone defect in femoral condyle using microencapsulated chitosan, nanohydroxyapatite/collagen and poly(l-lactide)-based microsphere-scaffold delivery system. Artif Organs. 2011;35:E119–28.
Gaveris K, Schneider U, Groll J, Schimdt-Rohfing B. BMP-7 loaded microspheres as a new delivery system for the cultivation of human chondrocytes in a collagen type-I gel: the common nude mouse model. Int J Artif Organs. 2010;33:45–53.
Lochmann A, Nitzsche H, von Einem S, Schwarz E, Mader K. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. J Control Release. 2010;147:92–100.
Cai J, Liu Y, Zhang L. Dilute solution properties of cellulose in LiOH/urea aqueous system. J Polym Sci B Polym Phys. 2006;44:3093–101.
Fan JJ, Bi L, Wu T, Cao LG, Wang DX, Nan KH, Chen JD, Jin D, Jiang S, Pei GX. A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin. J Mater Sci Mater Med. 2012;23:399–407.
Bi L, Cheng W, Fan H, Pei G. Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with antologous platelet-rich plasma. Biomaterials. 2010;31:3201–11.
Lee JY, Seol YJ, Kim KM, Lee YM, Park YJ, Rhyu IC, Chung CP, Lee SJ. Transforming growth factor (TGF)-beta 1 releasing tricalcium phosphate/chitosan microgranules as bone substitutes. Pharm Res. 2004;21:1790–6.
Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol. 2000;142:9–21.
Hench LL. Bioceramics. J Am Ceram Soc. 1998;81:1705–28.
Ho ML, Fu YC, Wang GJ, Chen HT, Chang JK, Tsai TH, Wang CK. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Control Release. 2008;128:142–8.
Habraken WJE, Wolke JGC, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59:234–48.
Fu HL, Rahaman MN, Day DE, Brown RF. Hollow hydroxyapatite microspheres as a device for controlled delivery of proteins. J Mater Sci Mater Med. 2011;22:579–91.
Fu HL, Rahaman MN, Brown RF, Day DE. Evaluation of bone regeneration in implants composed of hollow HA microspheres loaded with transforming growth factor β1 in a rat calvarial defect model. Acta Biomater. 2013;9:5718–27.
Xiao W, Fu HL, Rahaman MN, Liu YX, Bal BS. Hollow hydroxyapatite microspheres: a novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration. Acta Biomater. 2013;9:8374–83.
Mututuvari TM, Harkins AL, Tran CD. Facile synthesis, characterization, and antimicrobial activity of cellulose–chitosan–hydroxyapatite composite material: a potential material for bone tissue engineering. J Biomed Mater Res A. 2013;101:3266–77.
Pan Y, Zhao X, Guo YP, Lv XT, Ren SX, Yuan MR, Wang ZC. Controlled synthesis of hollow calcite microspheres modulated by polyacrylic acid and sodium dodecyl sulfonate. Mater Lett. 2007;61:2810–3.
Lane JM, Sandhu HS. Current approaches to experimental bone grafting. Orthop Clin North Am. 1987;18:213–25.
Wang Y, Moo YX, Chen C, Gunawan P, Xu R. Fast precipitation of uniform CaCO3 nanospheres and their transformation to hollow hydroxyapatite nanospheres. J Colloid Interface Sci. 2010;352:393–400.
She SD, Zhang BF, Jin CR, Feng QL, Xu YX. Preparation and in vitro degradation of porous three-dimensional silk fibroin/chitosan scaffold. Polym Degrad Stab. 2008;93(7):1316–22.
Pereira MM, Clark AE, Hench LL. Effect of texture on the rate of hydroxyapatite formation on gel-silica surface. J Am Ceram Soc. 1995;78:2463–8.
Sowjanya JA, Singh J, Mohita T, Sarvanan S, Moorthi A, Srinivasan N, Selvamurugan N. Biocomposite scaffolds containing chitosan/alginate/nano-silica for bone tissue engineering. Colloids Surf B. 2013;109:294–300.
Mygind T, Stiehler M, Baatrup A, Li H, Zou X, Flyvbjerg A, Kassem M, Bünger C. Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds. Biomaterials. 2007;28:1036–47.
Gu YF, Wang G, Zhang X, Zhang YD, Zhang CQ, Liu X, Rahaman MN, Huang WH, Pan HB. Biodegradable borosilicate bioactive glass scaffolds with a trabecular microstructure for bone repair. Mater Sci Eng C. 2014;36:294–300.
Chang ZQ, Hou TY, Wu XH, Luo F, Xing JC, Li ZQ, Chen QB, Yu B, Xu JZ, Xie Z. An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect. Int J Med Sci. 2013;10:1761–70.
Zhu WM, Wang DP, Peng LQ, Zhang XJ, Ou YK, Fen WZ, Lu W, Han Y, Zeng YJ. An experimental study on the application of radionuclide imaging in repairing bone defects. Artif Cells Nanomed Biotechnol. 2013;41:304–8.
Breithaupt-Faloppa AC, Lara PF, Santos MFD, Oliveira-Filho RM, Junior OC. Radioisotopic evaluation of bone repair after experimental surgical trauma. J Appl Oral Sci. 2004;12:78–83.
Niu XF, Feng QL, Wang MB, Guo XD, Zheng QX. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release. 2009;134:111–7.
Li B, Yohshii T, Hafeman AE, Nyman JS, Wenke JC, Guelcher SA. The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials. 2009;30:6768–79.
Bae KH, Wang LS, Kurisawa M. Injectable biodegradable hydrogels: progress and challenges. J Mater Chem B. 2013;1:5371–88.
Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun. 2008;369:774–80.
Acknowledgments
This work was financially supported by Key Project on Basic Research of Shanghai (Nos. 08JC1419200, 12JC1408500), the Natural Science Foundation of Shanghai Municipality (No. 13ZR1444200), and Research Funds for the Central Universities.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yao, AH., Li, XD., Xiong, L. et al. Hollow hydroxyapatite microspheres/chitosan composite as a sustained delivery vehicle for rhBMP-2 in the treatment of bone defects. J Mater Sci: Mater Med 26, 25 (2015). https://doi.org/10.1007/s10856-014-5336-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-014-5336-8